维普中文期刊产品整合服务
28篇 您的检索式:作者名="Seong Ho Yang"
    题名 作者 年代 出处 被引量
1Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer显示文摘AIM: To determine the efficacy of bevacizumab in patients with metastatic colorectal cancer (MCRC) who have failed prior chemotherapy without bevacizumab. METHODS: Between March 2002 and June 2010, 40 patients in South Korea with MCRC who were treated with bevacizumab plus chemotherapy as a second or later-line treatment were analyzed retrospectively for their overall response rate (ORR), overall survival (OS), and progression-free survival (PFS). The tumor responses were assessed using the RECIST (Response Evaluation Criteria in Solid Tumors) guidelines. RESULTS: All of the patients had progressed under prior chemotherapy without bevacizumab. Three patients (7.5%) exhibited an ORR, twenty one patients (52.5%) exhibited stable disease (SD), and fifteen patients (37.5%) exhibited disease progression. The median duration of the OS and PFS were 14.0 and 6.13 mo respectively. The median OSs were 16.60, 14.07 and 13.00 mo for second-line, third-line and fourth- or later-line treatments, respectively. The median PFSs were 7.23, 7.30 and 3.87 mo for the second-line, third-line and fourth- or later-line treatments, respectively. CONCLUSION: In patients with MCRC, bevacizumab combined chemotherapy may be beneficial during second- or later-line treatment.Lee Chun Park Ho Sup Lee Seong Hoon Shin Seun Ja Park Moo In Park Sung Yong Oh Hyuk Chan Kwon Jin ho Baek Young Jin Choi Myoung Joo Kang Yang Soo Kim 2012World Journal of Gastroenterology2012,18,10:3
2Phase Ⅱ study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma:consortium for improving survival of lymphoma(CISL)study显示文摘Background:The response rate and survival improvement for rituximab,a CD20-targeting monoclonal antibody,have been demonstrated in marginal zone lymphoma(MZL)as monotherapy and in combination with chemotherapeutic regimens,yet relapses still occur despite treatment completion.Thus,extending the period of remission in MZL patients remains an essential goal.This multicenter,single-arm,open-label phase II study evaluated the survival efficacy of 2 years of rituximab-maintenance therapy in patients with stage III-IV CD20-positive MZL who had responded to first-line R-CVP(rituximab,cyclophosphamide,vincristine,and prednisolone).The objective of this study was to determine whether rituximab maintenance following R-CVP warrants further investigation.Methods:Prior to rituximab-maintenance therapy,patients received 6-8 cycles of first-line R-CVP therapy for stage III-IV MZL.Rituximab(375 mg/m^(2)),cyclophosphamide(750 mg/m^(2)),and vincristine(1.4 mg/m^(2);maximum 2 mg)were administered via an intravenous infusion on day 1 of each 3-week cycle,while oral prednisolone(100 mg)was given on days 1-5 of each 3-week cycle.The patients who achieved complete response(CR),partial response(PR),or stable disease(SD)to R-CVP treatment,were prescribed rituximab-maintenance therapy which was administered intravenously at a dose of 375 mg/m^(2) every 8 weeks for up to 12 cycles.The primary endpoint was progression-free survival(PFS).Secondary endpoints were overall survival(OS)and treatment safety.Results:47 patients were enrolled,of whom,45(96%)received rituximab-maintenance treatment.Fifteen(33%)patients had nodal MZL.Following R-CVP first-line therapy,20(44%),22(49%),and 3(7%)patients achieved CR,PR,and SD,respectively.After a median follow-up of 38.2 months,their observed 3-year PFS rate was 81%.During the rituximab-maintenance,6 PR and 1 SD patients achieved CR following the administration of R-CVP.Elevated LDH and the presence of B symptoms were found to be significant prognostic factors for PFS(P=0.003)and demonstrated a 3-year OS rate of 90%.Rituximab-maintenance therapy was well tolerated,and the common treatment-emergent adverse events were sensory neuropathy(18%),myalgia(13%),fatigue(9%),and neutropenia(9%).Conclusion: Rituximab-maintenance therapy following first-line R-CVP demonstrated good PFS in patients with stage III-IV MZL, in addition to a favorable toxicity profile.Sung Yong Oh Won Seog Kim Jin Seok Kim Seok Jin Kim Dok Hyun Yoon Deok-Hwan Yang Won Sik Lee Hyo Jung Kim Ho-Young Yhim Seong Hyun Jeong Jong Ho Won Suee Lee Jee Hyun Kong Sung-Nam Lim Jun Ho Ji Kyung A.Kwon Gyeong-Won Lee Jae Hoon Lee Ho Sup Lee Ho-Jin Shin Cheolwon Suh 2019Cancer Communications2019,39,1:2
3Motor recovery mechanism of diffuse axonal injury: A combined study of transcranial magnetic stimulation and functional MRI显示文摘Sung Ho Jang Sang-Hyun Cho Yun-Hee Kim Sung H. You Seong Ho Kim Oryong Kim Dong Suk Yang Su min Son 2005Restorative Neurology and Neuroscience2005,,:1
4Stage Migration Effect on Survival in Gastric Cancer Surgery With Extended Lymphadenectomy: The Reappraisal of Positive Lymph Node Ratio as a Proper N-Staging显示文摘Seong-Ho Kong Hyuk-Joon Lee Hye Seong Ahn Jong-Won Kim Woo Ho Kim Kuhn Uk Lee Han-Kwang Yang 2012Annals of Surgery2012,,1:1
5Benefit of Early Statin Therapy in Patients With Acute Myocardial Infarction Who Have Extremely Low Low-Density Lipoprotein Cholesterol显示文摘Ki Hong Lee Myung Ho Jeong Ha Mi Kim Youngkeun Ahn Jong Hyun Kim Shung Chull Chae Young Jo Kim Seung Ho Hur In Whan Seong Taek Jong Hong Dong Hoon Choi Myeong Chan Cho Chong Jin Kim Ki Bae Seung Wook Sung Chung Yang Soo Jang Seung Woon Rha Jang Ho Bae Jeo 2011Journal of the American College of Cardiology2011,,16:1
6In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells显示文摘Eun Ji Gang Seung Hyun Hong Ju Ah Jeong Soo Han Hwang Seong Whan Kim II Ho Yang Chiyoung Ahn Hoon Han Hoeon Kim 2004Biochemical and Biophysical Research Communications2004,,1:1
7Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea显示文摘Ja Young Lee Hak Yang Kim Kyung Ho Kim Seong Man Kim Myoung Kuk Jang Joon Yong Park Jin Heon Lee Jin-Ho Kim Jae Young Yoo 2004Cancer Letters2004,,2:1
8Facile route to synthesize large-mesoporous γ-alumina by room temperature ionic liquids显示文摘Park Hoseok Seong Ho Yang Jun Young-Si 2007Chem Mater2007,19,3:1
9The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers显示文摘Won Hee Jang Young-Il Yang Sung Su Yea Youn Jae Lee Jin Ho Chun Hyeong-In Kim Mi Seong Kim Kye-Hyung Paik 2001Cancer Letters2001,,1:1
10Suppressed estrogen supply via extra-ovarian progesterone receptor membrane component 1 in menopause显示文摘In post-menopausal women,intra-mammary estrogen,which is converted from extra-ovarian estrone(E1),promotes the growth of breast cancer.Since the aromatase inhibitor letrozole does not suppress 17β-estradiol(E2)production from E1,high intra-mammary E1 concentrations impair letrozole's therapeutic efficacy.Progesterone receptor membrane component 1(Pgrmc1)is a non-classical progesterone receptor associated with breast cancer progression.In the present study,we introduced a Pgrmc1 heterozygous knockout(hetero KO)murine model exhibiting low Pgrmc1 expression,and observed estrogen levels and steroidogenic gene expression.Naïve Pgrmc1 hetero KO mice exhibited low estrogen(E2 and E1)levels and low progesterone receptor(PR)expression,compared to wild-type mice.In contrast,Pgrmc1 hetero KO mice that have been ovariectomized(OVX),including letrozole-treated OVX mice(OVX-letrozole),exhibited high estrogen levels and PR expression.Increased extra-ovarian estrogen production in Pgrmc1 hetero KO mice was observed with the induction of steroid sulfatase(STS).In MCF-7 cell,letrozole suppressed PR expression,but PGRMC1 knockdown increased PR and STS expression.Our presented results highlight the important role of Pgrmc1 in modulating estrogen production when ovary-derived estrogen is limited,thereby suggesting a potential therapeutic approach for letrozole resistance.Sang RLee Hyun Yang Seong Lae Jo Young Ho Lee Hye Won Lee Bae-keun Park Eui-Ju Hong 2021The Journal of Biomedical Research2021,35,3:1
11Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: Analysis of the Korean Acute Myocardial Infarction Registry显示文摘Futoshi Yamanaka Myung Ho Jeong Shigeru Saito Youngkeun Ahn Shung Chull Chae Seung Ho Hur Taek Jong Hong Young Jo Kim In Whan Seong Jei Keon Chae Jay Young Rhew In Ho Chae Myeong Chan Cho Jang Ho Bae Seung Woon Rha Chong Jin Kim Donghoon Choi Yang Soo Jan 2013Journal of Cardiology2013,,:1
12Preparation of carbonaceous spheres from suspensions of pitch materials显示文摘Yoon Seong Ho Park Yang Duk Mochida Isao 1992Carbon1992,30,:1
13Ni-dispersed fullerenes:Hydrogen storage and desorption properties显示文摘Weon Ho Shin Seong Ho Yang 2006Appl Phys Lett2006,88,05:1
14The -238 tumor necrosis factor-α promoter polymorphism is associated with decreased susceptibility to cancers显示文摘Won Hee Jang Young-Il Yang Sung Su Yea Youn Jae Lee Jin Ho Chun Hyeong-In Kim Mi Seong Kim Kye-Hyung Paik 2001Cancer Letters2001,,:1
15Effects of acupuncture stimulation on brain activation induced by cue-elicited alcohol craving显示文摘Acupuncture has been shown to be effective on alcohol use disorder.However,the underlying mechanism remains poorly understood.To investigate the effects of Shenmen(HT7)acupoint on brain activation induced by cue-elicited alcohol craving,30 right-handed healthy light to moderate alcohol drinkers were recruited from the community.They were randomly assigned to undergo acupuncture either at HT7(experimental acupoint,n=15)or Jingqu(LU8,control acupoint,n=15)acupoints.This randomized controlled study was performed in Daegu Haany University and Daegu-Gyeongbuk Medical Innovation Foundation,Republic of Korea.Recruitment and data collection were conducted from December 2018 to May 2019.The results showed that after acupuncture at HT7 acupoint,the activation of orbitofrontal cortex and dorsolateral prefrontal cortex was greatly increased,while the activation of dorsolateral prefrontal cortex was obviously reduced,and subject's craving for alcohol was reduced when he/she seeing alcohol-related video clips involving various alcohols(beer,wine,or soju)or drinking scenarios.Acupuncture at HT7 more greatly reduced subject's alcohol cravings than acupuncture at LU8 acupoint.These findings suggest that acupuncture can improve the self-control of mild to moderate social drinkers through the activation of the orbitofrontal cortex and dorsolateral prefrontal cortex,thereby reducing the craving for alcohol.The study protocol was approved by the Institutional Review Board of Daegu Haany University Korean Medicine Hospital,Republic of Korea(approval No.DHUMC-D-18026-PRO-02)on November 30,2018.Hyeok Gyu Kwon Seong Hun Choi Joon Ho Seo Chae Ha Yang Mi Young Lee 2022Neural Regeneration Research2022,17,5:1
16Stage Migration Effect on Survival in Gastric Cancer Surgery With Extended Lymphadenectomy: The Reappraisal of Positive Lymph Node Ratio as a Proper N-Staging显示文摘Seong-Ho Kong Hyuk-Joon Lee Hye Seong Ahn Jong-Won Kim Woo Ho Kim Kuhn Uk Lee Han-Kwang Yang 2012Annals of Surgery2012,,1:1
17Facile route to synthesize large-mesoporous T-alumina by room temperature ionic liquids 显示文摘Park Ho Seok Yang Seong Ho Jun Young-Si 2007Chem Mater2007,19,3:1
18Effect of substrate temperature on structural, optical and electrical properties of ZnO thin films deposited by pulsed laser deposition显示文摘Seong Jun Kang Yang Hee Joung Hyun Ho Shin Yung Sup Yoon 2008Journal of Materials Science: Materials in Electronics2008,,11:1
19One -step Funetionalization of Multi - walled Carbon Nanotubes by Radiation - induced Graft Polymerization and Their Application as Enzyme- free Biosensors 显示文摘Yang Dae Soo Jung De Jung Seong Ho Choi 2010Radiation Physics and Chemistry2010,,79:1
20Long-term Prognosis of the Jejunal Involvement of Crohn’s Disease显示文摘Soo-Kyung Park Suk-Kyun Yang Seong Ho Park Sang Hyoung Park Jong Wook Kim Dong-Hoon Yang Kee Wook Jung Kyung Jo Kim Byong Duk Ye Jeong-Sik Byeon Seung-Jae Myung Chang Sik Yu Jin-Ho Kim 2013Journal of Clinical Gastroenterology2013,,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费